Picture of Active Biotech AB publ logo

ACTI Active Biotech AB publ News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Active Biotech Acquires Rights To Patents Of Tasquinimod In Combination Therapy

May 22 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACQUIRES EXCLUSIVE RIGHTS TO PATENTS OF TASQUINIMOD IN COMBINATION THERAPY
    * EXCLUSIVE LICENSE AGREEMENT WITH WISTAR INSTITUTE OF ANATOMY AND BIOLOGY

Source text for Eikon:  ID:nMFN55R2hh 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Active Biotech AB publ

See all news